美国FDA将诺和诺德的Ozempic和Wegovy从药品短缺名单中删除

格隆汇
18 Jun

格隆汇6月18日|据路透,美国得克萨斯州的一名联邦法官支持美国食品和药物管理局(FDA)的决定,将诺和诺德的畅销药物Ozempic和Wegovy从药品短缺名单中删除,驳回了寻求继续复制药物的复合药房提出的挑战。

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10